Concepedia

Ruisheng Ke

RK

5

Publications

128

Citations

5

H-Index

2017

Active since

Affiliations

Fujian Medical University(Current)

Fuzhou General Hospital of Nanjing Military Command

First Affiliated Hospital of Xiamen University

Ruisheng Ke is an author at Fujian Medical University specializing in cancer research, pathology, and medicine.

ORCID

Top concepts

Publications per year

2017–2021

5

Publications

5

DNA topoisomerase IIα and Ki67 are prognostic factors in patients with hepatocellular carcinoma

Yi Cao, Ruisheng Ke, Shaohu Wang et al. · Oncology Letters · 2017 · 40 citations · Full text

Prognostic value and oncogene function of heterogeneous nuclear ribonucleoprotein A1 overexpression in HBV-related hepatocellular carcinoma

Ruisheng Ke, Kun Zhang, Lizhi Lv et al. · International Journal of Biological Macromolecules · 2019 · 32 citations

, , +11

miR-181b-5p Promotes the Progression of Cholangiocarcinoma by Targeting PARK2 via PTEN/PI3K/AKT Signaling Pathway

Zhelong Jiang, Fu-Xing Zhang, Hongliang Zhan et al. · Biochemical Genetics · 2021 · 22 citations

, , +9

A Novel Ferroptosis-Related Gene Signature For Clinically Predicting Recurrence After Hepatectomy of Hepatocellular Carcinoma Patients.

Huaxiang Wang, Fengfeng Xu, Ruisheng Ke et al. · 2021 · 20 citations · Full text

Prognostic value of heterogeneous ribonucleoprotein A1 expression and inflammatory indicators for patients with surgically resected hepatocellular carcinoma: Perspectives from a high occurrence area of hepatocellular carcinoma in China

Ruisheng Ke, Lizhi Lv, Jiayan Li et al. · Oncology Letters · 2018 · 14 citations · Full text

, , +19

Rows per page

1–5 of 5